DeepBowel Study: Advanced Molecular Profiling to Transform Celiac Disease Diagnosis and Management — What Clinicians Need to Know
247 Health News Editorial
·4 May 2026
·3 min read
·clinical-trialsThe DeepBowel Study combines traditional histopathology with advanced molecular profiling to revolutionize celiac disease diagnosis and management. This Finnish research could transform how clinicians approach small-bowel disorders through AI-powered analysis and transcriptomic profiling.
Originally reported by ClinicalTrials.gov
References
- 1.Tampere University Hospital. (2024). Histological and Molecular Profiling in the Diagnostics and Treatment of Small-Bowel Diseases - A Prospective Cohort Study (The DeepBowel Study) [Clinical trial registration NCT07556328]. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07556328
- 2.Taavela, J., Kurppa, K., Collin, P., Lähdeaho, M. L., Salmi, T., Saavalainen, P., Haimila, K., Huhtala, H., Laurila, K., Sievänen, H., Partanen, J., Mäki, M., & Kaukinen, K. (2022). Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clinical Gastroenterology and Hepatology, 20(3), 682-691.e4. https://doi.org/10.1016/j.cgh.2021.07.030
- 3.Malamut, G., Afchain, P., Verkarre, V., Lecomte, T., Amiot, A., Damotte, D., Bouhnik, Y., Colombel, J. F., Delchier, J. C., Allez, M., Cosnes, J., Lavergne-Slove, A., Meresse, B., Trinquart, L., Macintyre, E., Radford-Weiss, I., Hermine, O., & Cellier, C. (2009). Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology, 136(1), 81-90. https://doi.org/10.1053/j.gastro.2009.01.069
- 4.Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., Lundin, K. E., Murray, J. A., Sanders, D. S., Walker, M. M., Zingone, F., & Ciacci, C. (2013). The Oslo definitions for coeliac disease and related terms. Gut, 62(1), 43-52. https://doi.org/10.1136/gutjnl-2011-301346
- 5.Singh, P., Arora, A., Strand, T. A., Leffler, D. A., Catassi, C., Green, P. H., Kelly, C. P., Ahuja, V., & Makharia, G. K. (2018). Global prevalence of celiac disease: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(6), 823-836.e2. https://doi.org/10.1016/j.cgh.2017.06.037
- 6.Marsh, M. N. (1992). Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity. Gastroenterology, 102(1), 330-354. https://doi.org/10.1016/0016-5085(92)90524-6
- 7.Rubio-Tapia, A., & Murray, J. A. (2010). Classification and management of refractory coeliac disease. Gut, 59(4), 547-557. https://doi.org/10.1136/gut.2009.195131
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service